MEP Cristian Buşoi (EPP, RO) has the pleasure to invite you to the ‘Launch of a Research Roadmap for Liver Disease (HEPAMAP) – Case study for chronic diseases & research’, A European Parliament seminar organised in collaboration with the European Association for the Study of the Liver (EASL).
10 December 2014, 15.00 – 17.00 | Venue: The European Parliament, Alteiro Spinell (Brussels). Room: A3F383
—-
Launch of a Research Roadmap for Liver Disease (HEPAMAP) – AGENDA
—–
[<img7782|center>
->http://my.epha.org/civicrm/event/info?id=201&reset=1]
Event hosted by MEP Cristian-Silviu BUŞOI (EPP, RO)
—-
The HEPAMAP is intended to be both:
—–
- (1) a tool for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda and also;
- (2) an advocacy tool to raise awareness more generally of liver disease and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.
—-
Speakers will include
—–
- Prof. M Peck (AUT)
- Prof Helen Reeves (UK)
- Alessio Aghemo (IT)
- Professor Maria Beatriz da Silva Lima Chair of IMI2 Scientific Panel
- Grigorij Kogan, PhD, DSc.Research Programme Officer Responsible for the area of Chronic Diseases, EU Commission
- Mr Achim Kautz, Policy Director at The European Liver Patients Association (ELPA)
—–
Objectives of the event:
——
- Introduce Hepamap and EASL to policy makers and stakeholders in the EU research and public health communities
- Emphasise the links between liver and other disease areas, as well as the cross-overs between liver disease risk factors
- Highlight the support provided by Hepamap to Horizon 2020 in achieving its health research goals and objectives
- Contribute to more awareness of the need to fund liver research and obtain commitments from decision and policy makers to do so within their specific remits
—-
Who should attend?
——
The event/workshop will be of particular interest and importance for the representatives of civil society organisations, EU institution and Members States representatives, researchers and other stakeholders dealing directly and indirectly with chronic diseases and health related research, wishing to learn about links between lifestyle determinants of health and chronic diseases; find out more about the impact of Horizon 2020 and IMI2 on EU health policy; receive updates on recent scientific and policy developments at EU policy level; explore opportunities for increased advocacy and use of EU funds on a health-risk factors link; and build up and/or expand their cross-sectoral network for future partnerships and collaboration.
————————————–
– REGISTER HERE (deadline: Friday, 5 December 2014)
————————————
The seminar is free of charge; the organisers do NOT cover any travel or accommodation costs.
For further information related to this event, please contact Claudia Almeida (EPHA) at claudia@epha.org
Spread the word on Twitter using #HEPAMAP <img7722|left>
—–
About EASL
——
EASL is an EPHA-member organisation which is based in Geneva and is a membership organisation for hepatology health professionals. EASL currently has just over 4,000 members from over 100 countries. The EASL annual congress now attracts over 10,000 participants and is the biggest medical liver congress in the world. EASL will celebrate its 50th anniversary in 2015 but has only recently opened a secretariat and office in Geneva. EASL wants to significantly increase its profile in Brussels and be much more pro-active in raising awareness of liver disease and alcohol harm at EU level.
More information about the Association for the Study of the Liver (EASL)
